Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng Ma

Showing results (341-350 of 346) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 346 results.
Vaccines|June 24, 2022
Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 VariantsYuntao Zhang, Wenjie Tan, Zhiyong Lou, et al.
The Journal of Clinical Investigation|December 2, 2014
Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosisMadhav C Menon, Peter Y Chuang, Zhengzhe Li, et al.
The Oncologist|April 8, 2021
Analysis of Real-World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death-1 and Programmed Cell Death-Ligand 1 Inhibitors in Advanced Non-Small Cell Lung CancersKristin L Ayers, Tommy Mullaney, Xiang Zhou, et al.
The Journal of Clinical Investigation|October 17, 2017
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanomaYao Zhan, Jun Guo, William Yang, et al.
The Journal of Clinical Investigation|April 15, 2024
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanomaYao Zhan, Jun Guo, William Yang, et al.
The Lancet. Infectious Diseases|September 18, 2021
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trialShengLi Xia, YunTao Zhang, YanXia Wang, et al.
Pageof 35

Showing results (341-350 of 346) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 346 results.
Vaccines|June 24, 2022
Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 VariantsYuntao Zhang, Wenjie Tan, Zhiyong Lou, et al.
The Journal of Clinical Investigation|December 2, 2014
Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosisMadhav C Menon, Peter Y Chuang, Zhengzhe Li, et al.
The Oncologist|April 8, 2021
Analysis of Real-World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death-1 and Programmed Cell Death-Ligand 1 Inhibitors in Advanced Non-Small Cell Lung CancersKristin L Ayers, Tommy Mullaney, Xiang Zhou, et al.
The Journal of Clinical Investigation|October 17, 2017
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanomaYao Zhan, Jun Guo, William Yang, et al.
The Journal of Clinical Investigation|April 15, 2024
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanomaYao Zhan, Jun Guo, William Yang, et al.
The Lancet. Infectious Diseases|September 18, 2021
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trialShengLi Xia, YunTao Zhang, YanXia Wang, et al.
Pageof 35